Navigation Links
Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States
Date:9/29/2013

d product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn's disease and severe asthma.  The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells.  The Company's growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors.

Immune is headquartered in Tarrytown, New York, with its primary research and development facilities in Herzliya-Pituach, Israel. 

For more information, visit Immune's website at www.immunepharmaceuticals.com.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal" or the negative of those words or other comparable words to be uncertain and forward-looking.  Such forward-looking statements include statements that express plans, anticipation, intent, contingency, goals, targets, future development and are otherwise not statements of historical fact. These statements are based on our current expectations and are subject to risks and uncertainties that could cause actual results or developments to be materially different from historical results or from any future results expressed or
'/>"/>

SOURCE Immune Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
2. Immune Pharmaceuticals Inc. Trading Symbol is Now IMNP on Both NASDAQ OMX Stockholm Exchange and OTCQX Trading Platform
3. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
4. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
5. Inovio Pharmaceuticals Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
6. EpiCept Stockholders Overwhelmingly Approve Final Conditions to Merger with Immune Pharmaceuticals Ltd.
7. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
8. aTyr Pharma Completes $49 Million Financing to Advance a Therapeutic Pipeline for Rare Autoimmune Diseases from a Newly Discovered Class of Proteins, Physiocrines
9. RuiYi et Genor BioPharma collaborent au développement du RYI-008 en Chine, un nouveau traitement contre les maladies auto-immunes et le cancer
10. RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
11. Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
(Date:1/14/2014)... Critical Care, a LifeCentre partner practice, located at 165 Fort Evans ... in Loudoun County to receive a small ... Barnes , Medical Director, is a well-seasoned veterinarian of more than ... are avid scuba divers. "As altitude skiers and hikers, we recognize ...
(Date:1/14/2014)... 14, 2014 Equashield ( http://www.equashield.com ... drugs, today announced that it has achieved 60% ...   Equashield,s closed systems reduce the ... and other medical professionals who prepare and administer ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... data presented today at the Society for Cardiovascular ... first to look at the use of highly ... detect restricted blood flow to the heart in ... Preliminary results from the ST-DETECT Trial using high-fidelity ...
... 2011 At the 2011 European Society for Therapeutic ... ExCel Centre in London, Elekta will demonstrate advanced solutions ... improve lives of cancer patients worldwide. This includes Elekta,s ... staff confidence in the integrity of patient identification and ...
Cached Medicine Technology:New Data Provide First Look at Ability to Detect Life-Threatening Heart Problems in Some High-Risk Patients 2New Data Provide First Look at Ability to Detect Life-Threatening Heart Problems in Some High-Risk Patients 3Elekta to Demonstrate Advanced Solutions for Managing Cancer Safely and Effectively at ESTRO 2011 2Elekta to Demonstrate Advanced Solutions for Managing Cancer Safely and Effectively at ESTRO 2011 3
(Date:4/18/2014)... Calif. (April 18, 2014) ― A new study in ... weekly patterns in health-related Google searches reveals a recurring ... strategies. , Investigators from San Diego State ... the Monday Campaigns, analyzed "healthy" Google searches (searches that ... "healthy diet") originating in the U.S. from 2005 to ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... will benefit European citizens and the European medical industry ... laboratory bench to the bedside. For Europe and for ... of great importance for the quality of life of ... , To achieve this important objective, the European ...
... Pittsburgh,s Fifth Avenue Place and Penn Avenue Place buildings, ... conserve additional energy by participating in Earth Hour on ... Inc. announced today that its energy conservation efforts in ... the reduction of lighting and heating and air conditioning ...
... New York, March 12 Yesterday,s ... the release of United States funding for UNFPA, the United ... women,s health, rights and equality, according to UNFPA Executive Director ... girls and their families around the world," said Ms. Obaid. ...
... March 12 Following a successful two-year campaign of ... Women movement, CUTCO Cutlery has announced that it is ... March 2009, CUTCO donated more than $274,000 to Go ... and more than $74,000 raised through a 10 percent ...
... A. Barry Rand to take over as CEO for ... The nation,s largest membership organization, AARP, will appoint A. ... change and inclusion in the workplace, to become CEO ... the position for eight years. Rand will be ...
... congressman to lead debate on improving patient careWASHINGTON, March ... today announced that Tony Coelho will serve as chairperson ... congressman and primary author of the Americans with Disabilities ... people with disabilities for 40 years."I,m excited about the ...
Cached Medicine News:Health News:Better health and prosperity in Europe via improved clinical research 2Health News:Highmark Facilities Reduced Energy Consumption by 5.6 Percent in 2008 2Health News:Highmark Facilities Reduced Energy Consumption by 5.6 Percent in 2008 3Health News:U.S. Resumption of UNFPA Funding to Boost Women's Health and Rights 2Health News:CUTCO Cutlery Extends Its Support of Go Red For Women 2Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 2Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 3Health News:Agent for Social Change to Lead Nation's Largest Membership Organization 4Health News:Tony Coelho is Named New Chair of Coalition for Comparative Effectiveness Research 2
... dye, used in matured cataract surgery, which ... enables the surgeon to see capsule ... trypan blue combined with sodium chloride and ... intraocular injection into the anterior chamber of ...
Blanket protection against heavier bleeding....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Refkeratometer...
Medicine Products: